Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - Digestive Disease Week (DDW 2014)

Optimizing Therapy with Biologic Agents in Inflammatory Bowel Disease

Chicago, Illinois / May 3-6, 2014

Chicago - Oral and poster presentations at DDW 2014 reflected the changes that have evolved in the approach to treatment of inflammatory bowel disease as new data have been accumulated on the use of the tumor necrosis factor alpha (TNF)...

PRIORITY PRESS - 2014 Genitourinary Cancers Symposium

Cardiovascular Risk with ADT for Advanced Prostate Cancer

San Francisco, California / January 30-February 1, 2014

San Francisco - The principal goal of androgen deprivation therapy (ADT) is to reduce testosterone to castrate levels, thereby depriving prostate cancer cells of their key growth substrate. However, several studies have shown that ADT...

PRIORITY PRESS - 23rd Annual Canadian Conference on HIV/AIDS Research (CAHR)

Global Gains in the HIV Epidemic: Intensified and Simplified Treatment Regimens

St. John’s, Newfoundland and Labrador / May 1-4, 2014

St. John’s - Since the mid 90s, there has been a virtual explosion of novel antiretroviral therapies (ART) targeting HIV replication along multiple pathways. This has led to the development of potent new combinations of ARTs that are...

MEDI-NEWS - Based on Guidelines Prepared by the Meningococcal B Pilot Project Task Group

Young Infants and the Multi-Component Serogroup B Vaccine: New NACI Recommendations for Healthcare Professionals

March 26, 2014

Invasive meningococcal disease (IMD) is an acute and serious infection caused by the bacterium Neisseria meningitidis. In Canada, 5 serogroups are responsible for IMD, of which serogroup B is now the most prevalent, especially among infants...

PRIORITY PRESS - 7th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

New Treatment Strategies for Prophylaxis in Severe Hemophilia: Moving from Clinical Trials into Real World Practice

Brussels, Belgium / February 26-28, 2014

Brussels - The focus of care in hemophilia A and B has shifted from the management of acute bleeding episodes (on-demand therapy) toward prophylaxis to prevent bleeding episodes and disease sequelae. Currently, hemophilia A patients...

PHYSICIAN PERSPECTIVE - Viewpoint based on current literature and presentations from the 19th Canadian Digestive Disease Week (CDDW) & 8th Annual CASL Winter Meeting

Update on Bowel Preparation Agents: Considering Efficacy, Tolerability and Safety for Optimal Compliance

Toronto, Ontario / February 8-11, 2014

Guest Editors:Stephen VannerProfessor of Medicine and PhysiologyQueen’s UniversityKingston, Ontario  Lawrence HookeyAssociate Professor of MedicineQueen’s UniversityKingston, Ontario Introduction The effectiveness of...

MEDICAL FRONTIERS - 9th Congress of the European Crohn's and colitis Organisation (ECCO-IBD 2014)

New Insights into Strategies for Management of Crohn’s Disease and Ulcerative Colitis

Copenhagen, Denmark / February 20-22, 2014

Copenhagen - Numerous clinical trials have demonstrated the therapeutic value of treatment with monoclonal anti-TNF-a antibodies such as infliximab and adalimumab in luminal and/or fistulizing Crohn’s disease or ulcerative colitis,...

MEDICAL OPTIONS - Respirology

Perspectives on Pulmonary Arterial Hypertension (PAH) - Reviews from published literature

February 2014

The 6-Minute Walk Test: Rethinking Outcome Measures in PAH Editorial ReviewWritten by: Theodore Bosworth Paul Hernandez, MDCM, FRCPCRespirologist, QEII Health Sciences CentreProfessor, Department of MedicineDalhousie UniversityHalifax,...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from Vascular 2013

SGLT2 Inhibitors: A Multi-Pronged Tool Against Type 2 Diabetes

Montreal, Quebec / October 17-20, 2013

Guest Editors: Philip A. McFarlane, MD, PhD, FRCPCDivision of NephrologySt. Michael’s HospitalUniversity of TorontoToronto, Ontario Ronald M. Goldenberg, MD, FRCPC, FACELMC Diabetes & EndocrinologyThornhill,...

PAGE 10 OF 124   1 2 3 4 5 6 7 8 9 10 ...